Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosis

Haematologica

Volumn 101, Issue 10, 2016, Pages e405-e406

  Gowin, Krisstina ^a   Coakley, Maria ^b   Kosiorek, Heidi ^a   Mesa, Ruben ^a  

^a MAYO CLINIC   (United States)

^b Department of Medicine National University of Ireland Cork   (Ireland)

Author keywords

Post essential thrombocytosis myelofibrosis; Post polycythemia vera; Primary myelofibrosis; Prognostic scores

Indexed keywords

CALRETICULIN; HEMOGLOBIN;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; CELL THERAPY; CYTOPENIA; FEMALE; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYELOID METAPLASIA; OVERALL SURVIVAL; POLYCYTHEMIA VERA; PROGNOSTIC ASSESSMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTOSIS; BLOOD; BLOOD CELL COUNT; MIDDLE AGED; PROGNOSIS; RISK FACTOR; STANDARDS; THROMBOCYTHEMIA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CELL COUNT; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYCYTHEMIA VERA; PRIMARY MYELOFIBROSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOCYTHEMIA, ESSENTIAL;

EID: 84989322208     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2016.149013     Document Type: Letter

References (12)

1. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol. 2005;23(33):8520-8530.
2. Passamonti F, Cervantes F, Vannucchi AM, et al. Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis. Blood. 2010;116(15):2857-2858.
3. Passamonti F, Rumi E, Caramella M, et al. A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis. Blood. 2008;111(7):3383-3387.
4. Dupriez B, Morel P, Demory JL, et al. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood. 1996;88(3):1013-1018.
5. Cervantes F, Dupriez B, Pereira A, et al. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood. 2009;113(13):2895-2901.
6. Gangat N, Caramazza D, Vaidya R, et al. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol. 2011; 29(4):392-397.
7. Vannucchi AM, Guglielmelli P, Rotunno G, et al. Mutation enhanced international prognostic scoring system (MIPSS) for primary myelofibrosis: an AGIMM and IWG-MRT project. Blood. 2014;124(21):405.
8. Tefferi A, Guglielmelli P, Finke C, el al. Integration of mutations and karyotype towards a genetics-based prognostic scoring system (GPSS) for primary myelofibrosis. Blood. 2014;124(21):406.
9. Bose P, Verstovsek S. The evolution and clinical relevance of prognostic classification systems in myelofibrosis. Cancer. 2016;122(5):681-692.
10. Boiocchi L, Mathew S, Gianelli U, et al. Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stage. Mod Pathol. 2013;26(12):1577-1585.
11. Tefferi A, Guglielmelli P, Lasho TL, et al. CALR and ASXL1 muta-tions-based molecular prognostication in primary myelofibrosis: an international study of 570 patients. Leukemia. 2014;28(7):1494-1500.
12. Rotunno G, Pacilli A, Artusi V, et al. Epidemiology and clinical relevance of mutations in post-polycythemia vera and post-essential thrombocythemia myelofibrosis. A study on 359 patients of the AGIMM group. Am J Hematol. 2016;91(7):681-686.